BioSpace News Archive

Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced it received funding from the Crohn’s & Colitis Foundation’s IBD Ventures under a program to accelerate research and development that aim to improve the quality of life for patients with IBD.

Servier and Aqemia announce the extension of their new-molecule discovery collaboration on an undruggable therapeutic target in immuno-oncology.

Regenative Labs (Regenative), a leading HCT/P manufacturer has published a case study in the Journal of Biomedical Research and Environmental Sciences alongside Dr. Alan Meglin, of Advanced Regenerative Therapy in Georgia.

Immunocore announces strategic prioritiesincluding pipeline expansion for 2023-2024

Acutus Medical, Inc. today announced preliminary unaudited results for the fourth quarter and full year 2022.

Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, announced instrument shipments and preliminary unaudited fourth quarter 2022 revenue.

Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced its preliminary, unaudited fourth quarter and full-year 2022 revenue results.

Theravance Biopharma, Inc. announced its 2022 Accomplishments and 2023 Key Targets.

KemPharm, Inc. announced changes to its Board of Directors and executive leadership team as part of the Company’s ongoing business transformation initiatives.

G1 Therapeutics, Inc. (Nasdaq: GTHX) today announced the 2023 data readouts that are expected to drive its near-term and long-term indications and potential future treatment paradigms for some of the most aggressive and refractory cancers, including metastatic colorectal (mCRC), bladder or urothelial cancer (mUC), and triple negative breast cancer (TNBC).